ONE Bio Corp.
ONBI
$0.02
$0.029,900.00%
OTC PK
| 09/30/2011 | 06/30/2011 | ||||
|---|---|---|---|---|---|
| Revenue | 1.50% | 10.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.50% | 10.42% | |||
| Cost of Revenue | 7.10% | 15.18% | |||
| Gross Profit | -5.19% | 5.22% | |||
| SG&A Expenses | -9.62% | 7.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.46% | 12.52% | |||
| Operating Income | -3.17% | 5.72% | |||
| Income Before Tax | -29.32% | 3.09% | |||
| Income Tax Expenses | -32.13% | 6.55% | |||
| Earnings from Continuing Operations | -28.08% | 1.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 15.35% | -13.01% | |||
| Net Income | -28.29% | 1.48% | |||
| EBIT | -3.17% | 5.72% | |||
| EBITDA | -1.93% | 5.72% | |||
| EPS Basic | -34.94% | -1.60% | |||
| Normalized Basic EPS | -16.78% | -0.16% | |||
| EPS Diluted | -33.33% | -2.94% | |||
| Normalized Diluted EPS | -15.64% | -1.35% | |||
| Average Basic Shares Outstanding | 10.22% | 3.10% | |||
| Average Diluted Shares Outstanding | 8.75% | 4.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||